Drugmaker Divi’s Laboratories reported an 81% jump in first-quarter consolidated net profit at ₹492.06 crore.

In the year earlier period, it had reported a net profit of ₹272.44 crore.

The higher net profit came on the back of revenue from operations increasing 49% to ₹1,730.47 crore (₹1,162.88 crore).

Forex gain during the quarter was ₹5 crore as against a loss of ₹6 crore in the corresponding quarter of last year.

The company said it had near normal operations during the quarter, with minimal impact due to the COVID-19 pandemic.

While a significant part of ongoing capex programmes were completed in the last fiscal year, there was a delay in the completion of the balance work due to the non-availability of workmen with some contractors engaged for the projects, the firm said.

You have reached your limit for free articles this month.

To get full access, please subscribe.

Already have an account ? Sign in

Show Less Plan

Subscription Benefits Include

Today’s Paper

Find mobile-friendly version of articles from the day’s newspaper in one easy-to-read list.

Faster pages

Move smoothly between articles as our pages load instantly.

Unlimited Access

Enjoy reading as many articles as you wish without any limitations.


A one-stop-shop for seeing the latest updates, and managing your preferences.

Personalised recommendations

A select list of articles that match your interests and tastes.


We brief you on the latest and most important developments, three times a day.

*Our Digital Subscription plans do not currently include the e-paper ,crossword, iPhone, iPad mobile applications and print. Our plans enhance your reading experience.

Source link


Please enter your comment!
Please enter your name here